After Withdrawing Its $25 Million IPO, DermTech International Scores $2.4 Million

San Diego skin cancer diagnostics startup DermTech is developing gene classifiers and expression tests to help more accurately screen for dermatologic issues.

It just raised $2.4 million to do so, according to a regulatory filing – an interesting funding notice, given its announcement last year that it was readying for – and then withdrawing – a $25 million IPO. Poor market conditions, it said. Renaissance Capital writes:

Help employers find you! Check out all the jobs and post your resume.

Back to news